Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
313
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$9.65B
-
Value change
-
+$118M
-
Put/Call ratio
-
0.41
-
Number of buys
-
132
-
Number of sells
-
-185
-
Price
-
$132.18
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2021
409 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2021.
NovoCure Ltd - Common Stock (NVCR) has 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
of 112M outstanding shares and own 65.21% of the company stock.
Largest 10 shareholders include Capital International Investors (9.12M shares), FMR LLC (9.09M shares), BAILLIE GIFFORD & CO (8.86M shares), Capital World Investors (8.64M shares), VANGUARD GROUP INC (8.4M shares), BlackRock Inc. (6.42M shares), STATE STREET CORP (2.05M shares), MORGAN STANLEY (1.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.23M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.22M shares).
This table shows the top 313 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.